TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Freedom from Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the Insomnia Severity Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in wake after sleep onset (WASO)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Provider self-reported handoff effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: evolution of drusen in the macula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphological changes in the macula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-Emergent Adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Serious treatment-emergent adverse events (STEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-Emergent Adverse Reaction (TEAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Histopathological features of pediatric melanoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Molecular features of pediatric melanoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients in histological remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute changes in brain function and connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term changes in brain function and connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in patient-level penetration-electronic health record (EHR)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in patient-level penetration-patient reported outcome (PRO)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Self-efficacy to manage mTBI symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mTBI symptom burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition- fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life- Functional Assessment of Cancer Therapy - Prostate cancer (FACT-P)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mediterranean diet score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of ulcer closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Completion rate of virtual reality experiment without complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in activation in the primary motor cortex and cerebellum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate to target optimal landmark
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propensity to switch from rhGH to LAGH
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensory block level < T10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Block height discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abandonment of epidural or substitute for alternative method of analgesia after initial failure
Endpoint domain: Adverse events/effects
Primary endpoint: Impact of clipped lymph node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Area under the curve (AUC) of valacyclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol consumption in grams per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of scapular posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular lens tilt in degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean and peak velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repetitions performed until task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management outcomes of severe supratentorial massive intracerebral hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Head and Cervical Kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Kinematics and Kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of Mass and Center of Pressure (COM-COP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnoea-12 Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Total Corneal Fluorescein Staining (tCFS) at Day 60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Eye Dryness Score (Visual Analog Scale) at Day 60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak saccade amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Numeric Pain Rating Scale NPRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Universal goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xerostomia Questionnaire (XQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in non-calcified plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in total plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline physical activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative Speech Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing Function Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants Reporting one or More Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in performance of activities of daily living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Labour pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of resources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of resources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility as assessed through recruitment and retention rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 24-hour oral morphine milligram equivalents (OMEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bloodserum cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Heartrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Management of arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Management of amputee patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Adverse Drug Reaction during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with a local tolerability assessment (skin reaction score) >0 during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change in GP plasma concentration from Baseline to Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average REBECCA system usage rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Therapist Negative Beliefs about Exposure Scale (TBES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in size of large inflammatory HCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Joint Range of Motion Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neck Disability Index (NDI) for function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short Form Quality of Life 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse events and laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in arterial blood pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerable dose of orellanine
Endpoint domain: Physiological/clinical
Primary endpoint: Germ cell cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Asthma-related absences
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Emergency Department (ED) utilization for asthma by children
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hospitalization for asthma by children
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Oral corticosteroid steroid prescription for asthma by children
Endpoint domain: Adverse events/effects
Primary endpoint: Change in HECSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Differences in brain structure in terms of white matter volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in brain structure in terms of gray matter volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in brain metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain at lag screw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the value of fear of childbirth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum maternal satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Obstetric outcomes of childbirth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in apathy symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-Emergent Adverse Events and Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Awareness change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Screening rate change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic rate change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total number of physician diagnosed lower RTI and wheezing episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hepatology clinic referral rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: RBCs transfusion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptable Dressing Presence at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Cognitive Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mental State Examination Scale (MMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain functional activation (fNIRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: blood concentration of Sintilimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary antimicrobial proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in hemostatic potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in early joint-health markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety and tolerability of MT1013
Endpoint domain: Adverse events/effects
Primary endpoint: Two-Year Event-free Survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Sitting Medicine Ball Throwing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Push Up Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closed Kinetic Chain Upper Extremity Stability Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity Y Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC144-168,ss of cannabidiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax,144-168,ss of cannabidiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmin,144-168,ss of cannabidiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC144-168,ss of 7-OH-CBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax,144-168,ss of 7-OH-CBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement of the PRO score of the marker lesion at D57
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Clearance in LC-OCT of marker lesion at D57
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Assessment of local skin reaction grading scale at V2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: oral health impact profile for edentulous patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stool antigen retest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in FACIT-F score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Freedom from recurrent atrial arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stress Assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child mental well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in Physical Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time in designated saturation interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody levels in maternal blood after Tdap vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subclass antibody levels in maternal blood after Tdap vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody glycosylation in maternal blood after Tdap vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody functionality in maternal blood after Tdap vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants who experienced any targeted safety event related to study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who discontinue treatment and/or study related to any adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with any AE
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement of EASI-50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Continuous Performance Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Delis-Kaplan Executive Function System -Trail Making performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Delis-Kaplan Executive Function System Color Word Interference performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Wechsler Digit Span performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Wechsler Picture Span performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of complications associated with the participants surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Volume of bleeding associated with operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients requiring repeat colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Food Behavior Scale (FBS)
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Change in Children's Dietary Self-Efficacy Scale (CDSS)
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Change in Nutrition Attitude Subscale (NAS)
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Change in self-report on Activities of Daily Living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Global Success Rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seminal fluid analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cmax of ATI-2173, clevudine, and M1 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCtau of ATI-2173, clevudine, and M1 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of tenofovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of completion
Endpoint domain: Resource use
Primary endpoint: Change in Sedentary Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in functional ability for daily life tasks assessed on the FONE-FIM at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in functional ability assessed by the Barthel Index at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in functional ability for daily life tasks assessed on the FONE-FIM at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety as Assessed by Adverse Event Reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as Assessed by Slit-lamp Biomicroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Safety as Assessed by Best-corrected Distance LogMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of participants with a positive or negative test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UTI hospitalization rate
Endpoint domain: Adverse events/effects
Primary endpoint: urosepsis rates
Endpoint domain: Adverse events/effects
Primary endpoint: Lung volume at end-inspiration and end-expiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in blood ITGBL1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: VO2-Peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of high intensity exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of brain-derived neurotrophic factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of image quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quantitative comparison of image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal flow measured by Doppler
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ability to isolate live bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Occurrence of local reactogenicity signs and symptoms following receipt of any study product
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of systemic reactogenicity signs and symptoms following receipt of any study product
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse events (AEs) leading to early participant withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of subjects in clinical remission at Week 44
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary incontinence (UI) screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in usage of the provider clinical data dashboard
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serotonin binding potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of 68Ga-PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adherence to 4:3 Intermittent Fasting Dietary Paradigm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status